Claudia Cabrera Pastrana

4PUBLICATIONS
24CO-AUTHORS
Molecular targetsRegenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 13, 2026
Targeting Bruton's Tyrosine Kinase in CLL: Selectivity, Resistance Mechanisms, and Emerging Therapeutic Strategies.

|May 06, 2026
U2af1S34F and U2af1Q157R myeloid neoplasm-associated hotspot mutations induce distinct hematopoietic phenotypes in mice.

|Apr 09, 2026
Nonsense-Mediated RNA Decay Is a Targetable Vulnerability in Splicing Factor Mutant Myeloid Neoplasms by Enhancing R-Loop Accumulation and DNA Damage.

Claudia Cabrera Pastrana, Sridhar Nonavinkere Srivatsan, Michael O Alberti

|Nov 24, 2025
Sensitivity to ATR-CHK1 pathway inhibition in AML/MDS is enhanced by SRSF2 mutations and reduced by RUNX1 loss.

Samuli Eldfors, Sumit Rai, Vineet Sharma

Pageof 1

Frequent Collaborators

3 joint publications

Matthew Walter

3 joint publications

Timothy A Graubert

2 joint publications

Tareq Hossan

2 joint publications

Sridhar Nonavinkere Srivatsan